- Home
- TRUE vs INMB Comparison
TRUE vs INMB Comparison
Compare TRUE & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUE
- INMB
- Stock Information
- Founded
- TRUE 2005
- INMB 2015
- Country
- TRUE United States
- INMB United States
- Employees
- TRUE N/A
- INMB N/A
- Industry
- TRUE Computer Software: Programming Data Processing
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- TRUE Technology
- INMB Health Care
- Exchange
- TRUE Nasdaq
- INMB Nasdaq
- Market Cap
- TRUE 213.8M
- INMB 176.5M
- IPO Year
- TRUE 2014
- INMB 2019
- Fundamental
- Price
- TRUE $1.84
- INMB $8.74
- Analyst Decision
- TRUE Buy
- INMB Strong Buy
- Analyst Count
- TRUE 4
- INMB 3
- Target Price
- TRUE $4.17
- INMB $24.33
- AVG Volume (30 Days)
- TRUE 389.0K
- INMB 235.9K
- Earning Date
- TRUE 04-28-2025
- INMB 05-08-2025
- Dividend Yield
- TRUE N/A
- INMB N/A
- EPS Growth
- TRUE N/A
- INMB N/A
- EPS
- TRUE N/A
- INMB N/A
- Revenue
- TRUE $175,598,000.00
- INMB $42,000.00
- Revenue This Year
- TRUE $17.53
- INMB N/A
- Revenue Next Year
- TRUE $16.56
- INMB N/A
- P/E Ratio
- TRUE N/A
- INMB N/A
- Revenue Growth
- TRUE 10.64
- INMB N/A
- 52 Week Low
- TRUE $1.68
- INMB $4.32
- 52 Week High
- TRUE $4.62
- INMB $12.72
- Technical
- Relative Strength Index (RSI)
- TRUE 31.13
- INMB 51.37
- Support Level
- TRUE $1.68
- INMB $7.89
- Resistance Level
- TRUE $1.80
- INMB $8.50
- Average True Range (ATR)
- TRUE 0.11
- INMB 0.56
- MACD
- TRUE 0.03
- INMB 0.01
- Stochastic Oscillator
- TRUE 29.09
- INMB 66.30
About TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.